You have 9 free searches left this month | to do more

doxorubicin

Doxorubicin is a drug used to treat Breast Cancer, Lymphoma, Acute Lymphoblastic Leukemia, and other conditions. Doxorubicin is being actively studied in 202 studies and prior, has been studied in 198.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterDana-Farber Cancer InstituteZhao Weili
Hoffmann-La RocheMemorial Sloan Kettering Cancer CenterDi Deng
National Cancer Institute (NCI)M D Anderson Cancer CenterLewis B. Silverman, M.D.
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
2022-02-14
Feb 14, 2022
B
Recruiting
  • Liposarcoma, Dedifferentiated
  • BI 907828
  • Doxorubicin
  • Leuven, Belgium
    UZ Leuven
2022-04-04
Apr 4, 2022
E
Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • Doxorubicin
  • +2 more
  • (no location specified)
2021-10-08
Oct 8, 2021
C
Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
2021-11-12
Nov 12, 2021
U
Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-11-26
Nov 26, 2021
N
Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Duarte, California
    City of Hope
2022-02-17
Feb 17, 2022
G
Completed
  • Uterine or Soft Tissue Leiomyosarcoma
  • Villejuif, Val De Marne, France
    Gustave Roussy
2021-12-10
Dec 10, 2021
M
Active, not recruiting
  • Soft Tissue Sarcoma, Adult
  • Soft Tissue Sarcoma, Child
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-12-14
Dec 14, 2021
U
Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Focused Ultrasound
  • +2 more
  • Oxford, United Kingdom
    Oxford University Hospitals NHS Trust
2022-02-22
Feb 22, 2022
U
Active, not recruiting
  • Cervical Cancer
  • Leuven, Belgium
    UZLeuven
2021-01-26
Jan 26, 2021
W
Active, not recruiting
  • Sarcoma, Soft Tissue
  • +10 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-10
Mar 10, 2022
H
Recruiting
  • Pancreas Cancer
  • L-DOS47
  • Doxorubicin
  • Scottsdale, Arizona
  • +2 more
2022-03-16
Mar 16, 2022
M
Active, not recruiting
  • Sarcoma
  • Boston, Massachusetts
    Massachusetts General Hospital
2022-04-06
Apr 6, 2022
U
Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
2021-09-27
Sep 27, 2021
M
Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Doxorubicin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-07-14
Jul 14, 2021
P
Completed
  • Advanced Solid Tumors Amenable to Anthracycline Therapy
  • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
  • Münster, Germany
  • +1 more
2022-04-01
Apr 1, 2022
I
Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bintrafusp alfa
  • Doxorubicin
  • Bordeaux, France
  • +7 more
2021-12-06
Dec 6, 2021
A
Active, not recruiting
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Durvalumab and Tremelimumab
  • Doxorubicin
  • Hannover, Germany
    Medizinische Hochschule Hannover
2021-06-01
Jun 1, 2021
O
Recruiting
  • Soft Tissue Sarcoma
  • Bergen, Norway
  • +1 more
2021-09-10
Sep 10, 2021
T
Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
  • +4 more
2022-03-14
Mar 14, 2022
U
Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
2022-01-28
Jan 28, 2022
P
Recruiting
  • Soft Tissue Sarcoma
  • Onfekafusp alfa
  • Doxorubicin
  • Bad Saarow, Germany
  • +1 more
2020-11-25
Nov 25, 2020
W
Completed
  • Glioblastoma
  • MRI-guided Laser Heat Ablation (MLA)
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-08-26
Aug 26, 2021
I
Recruiting
  • Soft Tissue Sarcoma Adult
  • Bologna, BO, Italy
  • +12 more
2022-03-31
Mar 31, 2022